Precision Medicine: Going Digital To Drive Innovation

A large incentive for the rapid expansion of genomic testing, is the potential of precision medicine. The Precision Medicine Initiative is encouraging the prioritization of customized health care for patients suffering from cancers, patients undergoing molecular testing, and many others.

These tailored treatments require different types of data from multiple sources, creating a place for digitalization to help researchers and physicians personalize drug treatments and other forms of patient care. The Precision Medicine Initiative has a variety of benefits from the designing of new tools for building, analyzing, and sharing large sets of medical data, to improvements in FDA oversight of tests, drugs, and other technologies.